NDC 51662-1607

VASOPRESSIN

Vasopressin

VASOPRESSIN is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Vasopressin, Unspecified.

Product ID51662-1607_e6666508-8193-10f8-e053-2995a90a530f
NDC51662-1607
Product TypeHuman Prescription Drug
Proprietary NameVASOPRESSIN
Generic NameVasopressin
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-08-16
Marketing CategoryNDA /
Application NumberNDA204485
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameVASOPRESSIN, UNSPECIFIED
Active Ingredient Strength20 [USP'U]/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 51662-1607-1

1 mL in 1 VIAL (51662-1607-1)
Marketing Start Date2022-08-16
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "VASOPRESSIN" or generic name "Vasopressin"

NDCBrand NameGeneric Name
0517-1020VasopressinVasopressin
0548-9701VasopressinVasopressin
42367-570VASOPRESSINVASOPRESSIN
43598-085VasopressinVasopressin
51662-1314VASOPRESSINVASOPRESSIN
51662-1607VASOPRESSINVASOPRESSIN
52584-302VASOPRESSINvasopressin
55150-370VASOPRESSINVASOPRESSIN
55150-371VasopressinVasopressin
63323-302VasopressinVASOPRESSIN
70121-1642vasopressinvasopressin
42023-164VasostrictVasopressin
42023-190VasostrictVasopressin
42023-219VasostrictVasopressin
42023-220VasostrictVasopressin
42023-237VasostrictVasopressin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.